-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Two Cases from Shijiazhuang Sihua Pharmaceutical Group Selected for the 2024 Provincial Industrial Internet Benchmark List
Category:
发布时间：2024-12-17
【概要描述】
On December 16, the Hebei Provincial Department of Industry and Information Technology released the list of 2024 Provincial Industrial Internet Benchmark Cases, with two projects submitted by Shijiazhuang Sihua Pharmaceutical—“Development of a Manufacturing Execution System for Sterile Preparations” and “Construction Project of a Hyper-Converged Server Cloud Platform” by the Group’s Hebei Guangxiang Pharmaceutical Co., Ltd.—successfully selected.
On December 16, the Hebei Provincial Department of Industry and Information Technology released the list of 2024 Provincial Industrial Internet Benchmark Cases, with two projects submitted by Shijiazhuang Sihua Pharmaceutical—“Development of a Manufacturing Execution System for Sterile Preparations” and “Construction Project of a Hyper-Converged Server Cloud Platform” by Hebei Guangxiang Pharmaceutical Co., Ltd.—successfully selected.
As a leading enterprise in China’s large-volume parenteral solutions sector, Shijiazhuang Sihua Pharmaceutical has in recent years been vigorously advancing the digital transformation of sterile large-volume infusion manufacturing. The company has actively explored applications of the Industrial Internet, particularly by effectively integrating its enterprise resource planning system with its process control system in the infusion production workshop to build a Manufacturing Execution System centered on production management and quality control. This system enables comprehensive management and real-time tracking of production, quality, process, materials, equipment, and personnel throughout the key stages—from material input into production to finished-product output—thereby enhancing production efficiency while further reducing costs and improving product quality. Since the project’s implementation, production efficiency has increased by more than 30%, overall product costs have fallen by 10%, and the company’s production execution management has become more transparent, refined, and standardized.
Guangxiang Pharmaceutical, a subsidiary of the Group, serves as a key strategic hub for establishing the Group’s “API-plus-formulation” business model, accelerating industrial transformation, and strengthening and extending the industrial value chain. The company places great emphasis on digital transformation, leveraging its industry-specific characteristics and internal development needs to continuously advance the integration of informatization and industrialization. By fully harnessing cutting-edge information technologies and equipment to modernize traditional operations, Guangxiang has migrated digital production systems and business processes to the cloud, thereby enhancing product quality, reducing costs, and boosting operational efficiency. To date, the company has implemented advanced production control systems—including supply-chain management, fully automated water-production facilities, and automated three-dimensional warehousing—as well as a comprehensive financial management system. These initiatives have effectively integrated the enterprise’s logistics, information, and capital flows, accelerating the shift toward comprehensive digitalization and intelligent operations across production, business, and management, and continually empowering and elevating the company’s level of new-type industrialization.
It is reported that, in order to implement the spirit of documents such as the “Work Plan for Vigorously Developing Industrial Internet Platforms and Accelerating the Deep Integration of Industrialization and Informatization” issued by the Provincial Leading Group for Building a Strong Manufacturing Province, as well as the “14th Five-Year Plan for the Deep Integration and Development of Informatization and Industrialization in Hebei Province,” and to better summarize the successful experiences of benchmark demonstration projects in the industrial internet, develop typical cases tailored to specific sub-sectors or particular application scenarios, and provide replicable best practices for the digital transformation of industrial enterprises across the province, the Hebei Provincial Department of Industry and Information Technology has organized the selection of 2024 Hebei Provincial Industrial Internet Benchmark Cases. Following enterprise applications, review and recommendation by municipal departments of industry and information technology, expert evaluation, and public announcement, a total of 61 cases have been selected.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091